News | December 12, 2006

Blood Viscocity Test Predicts CV Disease

The Laboratory Services unit of Rheologics has launched a Whole Blood Viscosity (WBV) testing program for physicians. The company specializes in facilitating the study of blood viscosity and its relationship to cardiovascular disease.

For general practitioners and internists, knowing the viscosity of their patients' blood provides a critical tool in evaluating the efficiency and health of a cardiovascular system. The role that blood viscosity plays in cardiovascular health is substantial, the company states. Since the cardiovascular system is a closed system, the viscosity or thickness of what the heart is pumping directly affects the heart's efficiency and the damage done to the arteries by blood flow.

As part of the program, patients' blood specimens are drawn at their physicians' offices into standard lavender-top vacutainers (EDTA) and shipped overnight in a cold pack to Rheologics' laboratory facility in Exton, PA. Rheologics provides physicians with the specimen collection kits used for convenient packing and shipping. Test results include a graph of the WBV Profile of the patient's blood against a benchmark as well as an interpretive guide. The results are typically provided within 24 hours.

Rheologics Laboratory Services uses an innovative scanning capillary viscometer called the Rheolog to measure the biophysical properties of circulating blood and provide a complete and accurate WBV Profile. The Rheolog, an FDA IDE-exempt device, captures a patient's continuous blood viscosity over a broad range of shear rates that mimic blood flow in the human vascular system.

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing| April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing| March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing| January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing| March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init